Neurology News

The FDA has approved Crexont extended-release capsules for the treatment of Parkinson’s disease, according to the manufacturer.

Adults who received the recombinant zoster vaccine had a significantly lower risk for dementia over the next 6 years compared with live vaccine recipients, study results published in Nature Medicine revealed.

An eight-item questionnaire, called Central Aspects of Pain, reliably measures nociplastic pain across a variety of chronically painful musculoskeletal conditions, according to data published in Rheumatology.

PHILADELPHIA — An analysis of more than 15 million Americans enrolled in Medicare found that those enrolled in the Medicare Advantage plan had a 4% lower dementia diagnosis rate than those in traditional Medicare, according to a presenter.

New and chronic anxiety were associated with an increased risk for all-cause dementia, especially among individuals aged 70 years and younger, according to a study published in Journal of the American Geriatrics Society.

Individuals with a higher Brain Care Score had a significantly lower risk for late-life depression, dementia and stroke, according to a study published in Frontiers in Psychiatry.

PHILADELPHIA — Tackling 14 risk factors for dementia beginning in childhood could prevent or delay nearly half of cases, according to a report from the Lancet Commission presented at the Alzheimer's Association International Conference.

Increased social isolation may be linked to greater risks for several adverse health outcomes in older adults, according to a study published in JAMA Network Open.

Frequent use of touch-screen tablet games by toddlers may inhibit crucial interactions with their parents, according to preliminary research published in JAMA Network Open.

Mushroom-containing nootropic gummies sold at gas stations and smoke shops in Virginia contained unlabeled psilocybin and psilocin, according to results of an investigation published in Morbidity and Mortality Weekly Report.